Comprehensive Investigation on Acupuncture at ST-36 (Zusanli), SP-6 (Sanyinjiao) and PC-6 (Neiguan) in Veterinary Studies |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.18, No. 5)Publication Date: 2023-04-27
Authors : Amal Hammad; Shaaban Gadallah;
Page : 413-426
Keywords : Meridians; Phenomena; Analgesia; Acupoints; Mechanisms;
Abstract
Acupuncture at ST-36 [Zusanli], SP-6 [Sanyinjiao] and PC-6 [Neiguan] has gained increasing evidence of efficacy in management of variety of disorders. This chapter comprehensively investigated their therapeutic efficacy and mechanisms underlying their effects based on veterinary studies. Different studies demonstrated the efficacy of acutherapy at ST-36, SP-6 and PC-6 for treatment of various disorders in some animal models [for example, ST-36, SP-6 for pain and some immune-mediated diseases; ST-36 for intervertebral disc disease, certain arthritic models and skin problems; PC-6 for epilepsy and some ventricular arrhythmias; ST- 36, SP-6 and PC-6 for motility problems of gastrointestinal tract and hypertension, etc.]. Some studies also explained some of the mechanisms behind the therapeutic effects of these acupoints. Despite of this, the involved mechanisms need further investigations to promote the objectivity of their efficacy. Thus, in this chapter some future studies have been proposed to address this point as well as to evaluate the potential not previously addressed roles of these points in some disorders based on the relevant previous findings. All of these could increase the validity of ST-36, SP-6 and PC-6 acupuncture stimulation as a therapeutic tool in veterinary patients.
Other Latest Articles
- Study on the City Image of Maoming Based on Drone Photography Data
- ICT and Language Learning Interconnections: A Review of the Literature
- The Power of Motherhood: Resistance and Survival in “Beloved
- THE EFFICACY OF DYNAMIC TAPPING IN PATIENTS WITH TENNIS ELBOW A STUDY OF RANDOMISED CONTROLLED TRIAL
- CASE REPORT ON DRESS SYNDROME INDUCED BY ANTITUBERCULOSIS DRUGS
Last modified: 2024-10-18 21:46:35